At a glance
ClinicalIndex Comparison RecordN/ACompleted· 458 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Artero-venous Fistula, Prosthetic Polytetrafluoroethylene Grafts (AVG), Tunneled Cuffed Catheter (TCC): Impact of Vascular Access on HD Inflammation and Monocyte Activation
IRCCS Azienda Ospedaliero-Universitaria di Bologna·observational·Posted Feb 25, 2009·Updated Mar 18, 2021
In Brief
An observational study for Vascular Access for Hemodialysis and Inflammation. Completed, enrolled 458 participants across 1 site.
Detailed Summary
The aim of the present study was to investigate patients free of active infection and/or thrombosis to assess if the type of vascular access (AVF, AVG, TCC), could influence: 1. the levels of serological markers of inflammation (CRP, IL-6, TNF-a); 2. the degree of expression on monocyte surface of inflammation and immune response modulating molecules: CD14, CD32 and CD44. 3. the amount of monocytic cells expressing a senescent phenotype (CD14 and CD32).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2000
Primary CompletionDec 2006
Study CompletionDec 2008
First PostedFeb 2009
TodayJul 2026
First PostedFeb 25, 2009
Enrollment StartJan 1, 2000
Primary CompletionDec 1, 2006
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 17.4 years ago